Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Polyvalent DNA prime and envelope protein boost HIV-1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate.

Pal R, Wang S, Kalyanaraman VS, Nair BC, Whitney S, Keen T, Hocker L, Hudacik L, Rose N, Cristillo A, Mboudjeka I, Shen S, Wu-Chou TH, Montefiori D, Mascola J, Lu S, Markham P.

J Med Primatol. 2005 Oct;34(5-6):226-36.

2.

Urgently needed: a filter for the HIV-1 vaccine pipeline.

Moore JP, Burton DR.

Nat Med. 2004 Aug;10(8):769-71.

PMID:
15286768
3.

Immunogenicity of HIV-1 Env and Gag in baboons using a DNA prime/protein boost regimen.

Leung L, Srivastava IK, Kan E, Legg H, Sun Y, Greer C, Montefiori DC, zur Megede J, Barnett SW.

AIDS. 2004 Apr 30;18(7):991-1001.

PMID:
15096801
4.

HIV vaccine design and the neutralizing antibody problem.

Burton DR, Desrosiers RC, Doms RW, Koff WC, Kwong PD, Moore JP, Nabel GJ, Sodroski J, Wilson IA, Wyatt RT.

Nat Immunol. 2004 Mar;5(3):233-6. No abstract available.

PMID:
14985706
5.

HIV vaccines 1983-2003.

McMichael AJ, Hanke T.

Nat Med. 2003 Jul;9(7):874-80. Review.

PMID:
12835708
6.

Immunopathogenesis and immunotherapy in AIDS virus infections.

Letvin NL, Walker BD.

Nat Med. 2003 Jul;9(7):861-6. Review.

PMID:
12835706
7.

Antibody neutralization and escape by HIV-1.

Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, Shaw GM.

Nature. 2003 Mar 20;422(6929):307-12.

PMID:
12646921
8.

Prospects for vaccine protection against HIV-1 infection and AIDS.

Letvin NL, Barouch DH, Montefiori DC.

Annu Rev Immunol. 2002;20:73-99. Epub 2001 Oct 4. Review.

PMID:
11861598
9.

Vaccines for the prevention of HIV-1 disease.

Mascola JR, Nabel GJ.

Curr Opin Immunol. 2001 Aug;13(4):489-95. Review.

PMID:
11498307
10.

Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1.

Bures R, Gaitan A, Zhu T, Graziosi C, McGrath KM, Tartaglia J, Caudrelier P, El Habib R, Klein M, Lazzarin A, Stablein DM, Deers M, Corey L, Greenberg ML, Schwartz DH, Montefiori DC.

AIDS Res Hum Retroviruses. 2000 Dec 10;16(18):2019-35.

PMID:
11153085
11.

Human trials of HIV-1 vaccines.

Mulligan MJ, Weber J.

AIDS. 1999;13 Suppl A:S105-12. Review. No abstract available.

PMID:
10885769
13.

Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation Group.

Belshe RB, Gorse GJ, Mulligan MJ, Evans TG, Keefer MC, Excler JL, Duliege AM, Tartaglia J, Cox WI, McNamara J, Hwang KL, Bradney A, Montefiori D, Weinhold KJ.

AIDS. 1998 Dec 24;12(18):2407-15.

PMID:
9875578
14.

Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting.

Richmond JF, Lu S, Santoro JC, Weng J, Hu SL, Montefiori DC, Robinson HL.

J Virol. 1998 Nov;72(11):9092-100.

15.

The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens.

Wyatt R, Sodroski J.

Science. 1998 Jun 19;280(5371):1884-8. Review.

PMID:
9632381
16.

Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1/2 and V3 regions.

Lu S, Wyatt R, Richmond JF, Mustafa F, Wang S, Weng J, Montefiori DC, Sodroski J, Robinson HL.

AIDS Res Hum Retroviruses. 1998 Jan 20;14(2):151-5.

PMID:
9462925
17.

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination.

Letvin NL, Montefiori DC, Yasutomi Y, Perry HC, Davies ME, Lekutis C, Alroy M, Freed DC, Lord CI, Handt LK, Liu MA, Shiver JW.

Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9378-83.

18.

Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit.

Barnett SW, Rajasekar S, Legg H, Doe B, Fuller DH, Haynes JR, Walker CM, Steimer KS.

Vaccine. 1997 Jun;15(8):869-73.

PMID:
9234536
20.

Codon usage limitation in the expression of HIV-1 envelope glycoprotein.

Haas J, Park EC, Seed B.

Curr Biol. 1996 Mar 1;6(3):315-24.

Supplemental Content

Support Center